Martin Koestenberger1, Alexander Avian2, Andreas Gamillscheg1, Hannes Sallmon3, Gernot Grangl1, Ante Burmas1, Sabrina Schweintzger1, Stefan Kurath-Koller1, Gerhard Cvirn4, Georg Hansmann5. 1. Division of Pediatric Cardiology, Department of Pediatrics, Medical University Graz, Graz, Austria. 2. Institute for Medical Informatics, Statistics and Documentation, Medical University Graz, Graz, Austria. 3. Department of Pediatric Cardiology, Charité-Universitätsmedizin Berlin, Berlin, Germany. 4. Centre of Physiological Medicine, Medical University Graz, Graz, Austria. 5. Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany.
Abstract
BACKGROUND: Echocardiographic determination of RV end-systolic base/apex (RVES b/a) ratio was proposed to be of clinical value for assessment of pulmonary arterial hypertension (PAH) in adults. HYPOTHESIS: We hypothesized that the RVES b/a ratio will be affected in children with PAH and aimed to correlate RVES b/a ratio with conventionally used echocardiographic and hemodynamic variables, and with New York Heart Association (NYHA) functional class. METHODS: First we determined normal pediatric values for RVES b/a ratio in 157 healthy children (68 males; age range, 0.5-17.7 years). We then conducted an echocardiographic study in 51 children with PAH (29 males; age range, 0.3-17.8 years). RESULTS: RVES b/a ratio was lower compared with age- and sex-matched healthy controls (P < 0.001). In children with PAH, RVES b/a ratio decreased with worsening NYHA class. RVES b/a ratio inversely correlated with RV/LV end-systolic diameter ratio (ρ = -0.450, P = 0.001) but did not correlate with RV systolic function parameters (eg, tricuspid annular plane systolic excursion) and correlated with cardiac catheterization-determined pulmonary vascular resistance index (ρ = -0.571, P < 0.001). ROC analysis unraveled excellent performance of RVES b/a ratio to detect PAH in children (AUC: 0.95, 95% CI: 0.89-1.00, P < 0.001). CONCLUSIONS: The RVES b/a ratio decreased in children with PAH compared with age- and sex-matched healthy subjects. The RVES b/a ratio inversely correlated with both echocardiographic and hemodynamic indicators of increased RV pressure afterload and with NYHA class, suggesting that RVES b/a ratio reflects disease severity in PAH children.
BACKGROUND: Echocardiographic determination of RV end-systolic base/apex (RVES b/a) ratio was proposed to be of clinical value for assessment of pulmonary arterial hypertension (PAH) in adults. HYPOTHESIS: We hypothesized that the RVES b/a ratio will be affected in children with PAH and aimed to correlate RVES b/a ratio with conventionally used echocardiographic and hemodynamic variables, and with New York Heart Association (NYHA) functional class. METHODS: First we determined normal pediatric values for RVES b/a ratio in 157 healthy children (68 males; age range, 0.5-17.7 years). We then conducted an echocardiographic study in 51 children with PAH (29 males; age range, 0.3-17.8 years). RESULTS: RVES b/a ratio was lower compared with age- and sex-matched healthy controls (P < 0.001). In children with PAH, RVES b/a ratio decreased with worsening NYHA class. RVES b/a ratio inversely correlated with RV/LV end-systolic diameter ratio (ρ = -0.450, P = 0.001) but did not correlate with RV systolic function parameters (eg, tricuspid annular plane systolic excursion) and correlated with cardiac catheterization-determined pulmonary vascular resistance index (ρ = -0.571, P < 0.001). ROC analysis unraveled excellent performance of RVES b/a ratio to detect PAH in children (AUC: 0.95, 95% CI: 0.89-1.00, P < 0.001). CONCLUSIONS: The RVES b/a ratio decreased in children with PAH compared with age- and sex-matched healthy subjects. The RVES b/a ratio inversely correlated with both echocardiographic and hemodynamic indicators of increased RV pressure afterload and with NYHA class, suggesting that RVES b/a ratio reflects disease severity in PAH children.
Authors: Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller Journal: J Am Soc Echocardiogr Date: 2010-07 Impact factor: 5.251
Authors: Mark-Jan Ploegstra; Marcus T R Roofthooft; Johannes M Douwes; Beatrijs Bartelds; Nynke J Elzenga; Dick van de Weerd; Hans L Hillege; Rolf M F Berger Journal: Circ Cardiovasc Imaging Date: 2014-12-31 Impact factor: 7.792
Authors: Martin Koestenberger; Bert Nagel; William Ravekes; Alexander Avian; Bernd Heinzl; Gerhard Cvirn; Peter Fritsch; Andrea Fandl; Thomas Rehak; Andreas Gamillscheg Journal: Am J Cardiol Date: 2011-09-23 Impact factor: 2.778
Authors: Martin Koestenberger; Gernot Grangl; Alexander Avian; Andreas Gamillscheg; Marlene Grillitsch; Gerhard Cvirn; Ante Burmas; Georg Hansmann Journal: Circ Cardiovasc Imaging Date: 2017-01 Impact factor: 7.792
Authors: Jeffrey S Arkles; Alexander R Opotowsky; Jason Ojeda; Frances Rogers; Tong Liu; Vikram Prassana; Lucas Marzec; Harold I Palevsky; Victor A Ferrari; Paul R Forfia Journal: Am J Respir Crit Care Med Date: 2010-08-13 Impact factor: 21.405
Authors: Martin Koestenberger; Georg Hansmann; Christian Apitz; Heiner Latus; Astrid Lammers Journal: Paediatr Respir Rev Date: 2016-10-26 Impact factor: 2.726
Authors: Martin Koestenberger; Bert Nagel; William Ravekes; Alexander Avian; Ante Burmas; Gernot Grangl; Gerhard Cvirn; Andreas Gamillscheg Journal: Am J Cardiol Date: 2014-08-27 Impact factor: 2.778
Authors: Maria Jesus Del Cerro; Steven Abman; Gabriel Diaz; Alexandra Heath Freudenthal; Franz Freudenthal; S Harikrishnan; Sheila G Haworth; Dunbar Ivy; Antonio A Lopes; J Usha Raj; Julio Sandoval; Kurt Stenmark; Ian Adatia Journal: Pulm Circ Date: 2011 Impact factor: 3.017
Authors: Martin Koestenberger; Alexander Avian; Andreas Gamillscheg; Hannes Sallmon; Gernot Grangl; Ante Burmas; Sabrina Schweintzger; Stefan Kurath-Koller; Gerhard Cvirn; Georg Hansmann Journal: Clin Cardiol Date: 2018-08-18 Impact factor: 2.882